by Gabi Schaller | Jan 31, 2022 | News
January 31, 2022, VIENNA, AUSTRIA: Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from...
by Gabi Schaller | May 21, 2021 | News
Ribbon Biolabs successfully synthesises a 10 kbp DNA molecule using their FullGenes platform 21 May 2021, Vienna, Austria: The DNA Synthesis company Ribbon Biolabs announces the achievement of a key technology milestone, underlining its capability and potential. Using...
by Gabi Schaller | May 19, 2021 | News
For the first time ever, SynBioBeta is hosting a special, one-day special on all hot topics in biopharma. We are looking forward to meeting you there! Biopharma Conference...
by Gabi Schaller | Apr 29, 2021 | News
Prof. Eörs Szathmary of Eötvös University in Hungary has been elected to the Humanities and Social Sciences section of the Norwegian Academy of Sciences and Letters. As a member of Ribbon Biolabs’ Advisory Board, he has been supporting the companies development since...
